Clinical Studies on the Application of Concentrated Growth Factors for Enhancing the Recovery From Flap Ischemia–Reperfusion Injuries
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von BoQiao Zhou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hangzhou Third People's Hospital, Zhejiang, Hangzhou, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Surgical Flaps, Intercellular Signaling Peptides and Proteins, Plastic Surgery Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Medical Health Science and Technology Plans.
Abstract (Originalsprache)
Objective
To evaluate the therapeutic potential of locally injecting concentrated growth factor (CGF) into flaps for treating flap ischemia–reperfusion injury (FIRI) following reconstructive surgery.
Methods
Nineteen patients with FIRI were enrolled in this study. After clinical identification of ischemia–reperfusion (IR) injury, CGF was prepared from each patient's autologous blood and locally injected into the affected flap tissue. Flap viability was assessed using clinical indicators such as color, texture, and capillary refill. Patients were followed for 6 months postoperatively to assess long‐term outcomes.
Results
Seven days after CGF injection, 18 of 19 patients demonstrated complete flap survival. In one case, total necrosis occurred due to hematoma formation and insufficient dressing compression, but healing was achieved through dressing changes. Overall, patients showed improvements in flap color (from dark to ruddy), texture (softened), and skin tension (decreased), with visible wrinkle formation. Long‐term follow‐up confirmed satisfactory appearance and functional outcomes.
Conclusion
Local injection of CGF effectively enhances flap survival by promoting recovery from IR injury. This strategy may offer a promising adjunctive therapy in reconstructive procedures to improve tissue viability and healing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Hangzhou Third People's Hospital, Zhejiang, Hangzhou, China.
ORCID-Profile: BoQiao Zhou
Förderung
- Zhejiang Medical Health Science and Technology Plans
Zitieren
APA
Zhou, B., & Luo, X. (2025). Clinical Studies on the Application of Concentrated Growth Factors for Enhancing the Recovery From Flap Ischemia–Reperfusion Injuries. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70203
Vancouver
Zhou B, Luo X. Clinical Studies on the Application of Concentrated Growth Factors for Enhancing the Recovery From Flap Ischemia–Reperfusion Injuries. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70203
BibTeX
@article{Zhou2025,
author = {Zhou, BoQiao and Luo, XianYan},
title = {Clinical Studies on the Application of Concentrated Growth Factors for Enhancing the Recovery From Flap Ischemia–Reperfusion Injuries},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70203}
}
EUVIMED